Melanoma/Skin Cancer News

Clinicians may one day be able to treat immune checkpoint inhibitor-related myocarditis without disrupting cancer therapy, findings from a cellular investigation showed.

Healio will present its fourth annual Disruptive Innovators Awards for oncology/hematology this spring.

Adjuvant cemiplimab prolonged DFS compared with placebo for certain patients with cutaneous squamous cell carcinoma, according to the agent’s manufacturer.

A phase 3 study of Ameluz and RhodoLED photodynamic therapy for superficial basal cell carcinoma has reached a key milestone as the final patient has completed the 1-year follow-up visit, Biofrontera announced in a press release.

Recurrence-free survival and overall survival were more common in patients with nevus-associated acral melanoma compared with those with de novo acral melanoma, according to a study.

The risk for melanoma-related death increased among patients with T1 melanoma tumors thicker than 0.8 mm, according to a study.

Ambient ultraviolet radiation exposure and Merkel cell polyomavirus were both attributed to the development of Merkel cell carcinoma, whereas HIV, organ transplants and lymphocytic leukemia were not, according to a study.

Metformin may have potential in preventing nonmelanoma skin cancer, including in most populations with skin of color, according to a study.

U.S. Surgeon General Vivek Murthy, MD, MBA, issued an advisory today that includes several recommendations designed to reduce the impact of alcohol on cancer incidence and mortality.

The FDA has approved nivolumab and hyaluronidase-nvhy for subcutaneous injection in adults with solid tumors in which nivolumab is indicated, according to a press release.